ACT LAB Expands Operations with Acquisition of Florida Lab Assets from Green Scientific

LOS ANGELES– ACT LAB, a lab testing company in the legal cannabis and hemp markets, has recently announced its successful regulatory approval and completion of the acquisition of Florida lab operations and associated assets from Green Scientific Labs Holdings Inc. With this strategic move, ACT LAB is now on track to establish operations in eight states across the eastern region of the United States by the end of this year. By maintaining a consistent ownership structure and employing standardized testing methods and procedures, ACT LAB aims to enhance efficiency and ensure supply chain predictability across all its laboratories.

Michael Drozd, the CEO of ACT LAB, expressed enthusiasm regarding the acquisition, stating, “This expansion of ACT LAB’s geographical reach strengthens our leadership team and broadens our capabilities in cannabis and hemp testing, making us an unparalleled industry service provider. We possess all the necessary elements to become an indispensable partner for cultivators and processors in the multistate cannabis market, including top talent, leading-edge capabilities, and industry-setting standards. We are committed to showcasing our value to customers daily and anticipate further expansion in the months ahead.”

Additionally, ACT LAB confirmed the appointment of Rafael Bombonato, formerly the Chief Compliance Officer and Interim CEO of Green Scientific, as the Vice President of Quality for ACT LAB. Furthermore, Diana Asensio, who previously served as Green Scientific’s Lab Director for Florida, will continue in the same role within ACT LAB.

Rafael Bombonato shared his optimism about joining ACT LAB, emphasizing the enhanced services they can now offer. He stated, “As part of ACT LAB, we are positioned to deliver exceptional industry-leading turnaround times, unmatched customer service, and an extensive suite of capabilities that outshine any other lab in Florida. In my new role, I am eager to contribute to ACT LAB’s continued dominance in best-in-class testing methods and the establishment of even higher quality standards. These efforts will aid our customers in improving supply chain efficiency and predictability.”

ACT LAB’s recent acquisition of Green Scientific’s Florida lab assets signifies a strategic advancement for the company, expanding its operational presence and bolstering its position in the rapidly growing cannabis and hemp testing sector. With a clear focus on exceptional customer service, standardized testing protocols, and an extended geographic footprint, ACT LAB aims to solidify its standing as a trusted partner for businesses in the cannabis and hemp industries across multiple states.